Comparisons of α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats

MLA

Anna R. Connell, et al. “Comparisons of Α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats.” Journal of Ocular Pharmacology and Therapeutics, vol. 38, Mar. 2022, pp. 156–66. EBSCOhost, https://doi.org/10.1089/jop.2021.0084.

APA

Anna R. Connell, Michelle B. Hookham, Dongxu Fu, Derek P. Brazil, Timothy J. Lyons, & Jeremy Y. Yu. (2022). Comparisons of α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats. Journal of Ocular Pharmacology and Therapeutics, 38, 156–166. https://doi.org/10.1089/jop.2021.0084

Chicago

Anna R. Connell, Michelle B. Hookham, Dongxu Fu, Derek P. Brazil, Timothy J. Lyons, and Jeremy Y. Yu. 2022. “Comparisons of Α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats.” Journal of Ocular Pharmacology and Therapeutics 38 (March): 156–66. doi:10.1089/jop.2021.0084.